In vivo tumour imaging employing regional delivery of novel gallium radiolabelled polymer composites

Abstract Background Understanding the regional vascular delivery of particles to tumour sites is a prerequisite for developing new diagnostic and therapeutic composites for treatment of oncology patients. We describe a novel imageable 67Ga-radiolabelled polymer composite that is biocompatible in an...

Full description

Bibliographic Details
Main Authors: Ross W. Stephens, Gregory D. Tredwell, Jessica L. Bell, Karen J. Knox, Lee A. Philip, Tim J. Senden, Michael J. Tapner, Stephanie A. Bickley, Marcel R. Tanudji, Stephen K. Jones
Format: Article
Language:English
Published: American Association for the Advancement of Science (AAAS) 2021-03-01
Series:Biomaterials Research
Subjects:
Online Access:https://doi.org/10.1186/s40824-021-00210-0
_version_ 1797282020172234752
author Ross W. Stephens
Gregory D. Tredwell
Jessica L. Bell
Karen J. Knox
Lee A. Philip
Tim J. Senden
Michael J. Tapner
Stephanie A. Bickley
Marcel R. Tanudji
Stephen K. Jones
author_facet Ross W. Stephens
Gregory D. Tredwell
Jessica L. Bell
Karen J. Knox
Lee A. Philip
Tim J. Senden
Michael J. Tapner
Stephanie A. Bickley
Marcel R. Tanudji
Stephen K. Jones
author_sort Ross W. Stephens
collection DOAJ
description Abstract Background Understanding the regional vascular delivery of particles to tumour sites is a prerequisite for developing new diagnostic and therapeutic composites for treatment of oncology patients. We describe a novel imageable 67Ga-radiolabelled polymer composite that is biocompatible in an animal tumour model and can be used for preclinical imaging investigations of the transit of different sized particles through arterial networks of normal and tumour-bearing organs. Results Radiolabelling of polymer microspheres with 67Ga was achieved using a simple mix and wash method, with tannic acid as an immobilising agent. Final in vitro binding yields after autoclaving averaged 94.7%. In vivo stability of the composite was demonstrated in New Zealand white rabbits by intravenous administration, and intrahepatic artery instillations were made in normal and VX2 tumour implanted rabbit livers. Stability of radiolabel was sufficient for rabbit lung and liver imaging over at least 3 hours and 1 hour respectively, with lung retention of radiolabel over 91%, and retention in both normal and VX2 implanted livers of over 95%. SPECT-CT imaging of anaesthetised animals and planar imaging of excised livers showed visible accumulation of radiolabel in tumours. Importantly, microsphere administration and complete liver dispersal was more easily achieved with 8 μm diameter MS than with 30 μm MS, and the smaller microspheres provided more distinct and localised tumour imaging. Conclusion This method of producing 67Ga-radiolabelled polymer microspheres is suitable for SPECT-CT imaging of the regional vascular delivery of microspheres to tumour sites in animal models. Sharper distinction of model tumours from normal liver was obtained with smaller MS, and tumour resolution may be further improved by the use of 68Ga instead of 67Ga, to enable PET imaging.
first_indexed 2024-03-07T17:05:55Z
format Article
id doaj.art-6604bce6ff884428b4aa04740f8ffd1a
institution Directory Open Access Journal
issn 2055-7124
language English
last_indexed 2024-03-07T17:05:55Z
publishDate 2021-03-01
publisher American Association for the Advancement of Science (AAAS)
record_format Article
series Biomaterials Research
spelling doaj.art-6604bce6ff884428b4aa04740f8ffd1a2024-03-03T02:35:42ZengAmerican Association for the Advancement of Science (AAAS)Biomaterials Research2055-71242021-03-012511910.1186/s40824-021-00210-0In vivo tumour imaging employing regional delivery of novel gallium radiolabelled polymer compositesRoss W. Stephens0Gregory D. Tredwell1Jessica L. Bell2Karen J. Knox3Lee A. Philip4Tim J. Senden5Michael J. Tapner6Stephanie A. Bickley7Marcel R. Tanudji8Stephen K. Jones9The Biomedical Radiochemistry Laboratory, Department of Applied Mathematics, Research School of Physics, Australian National UniversityThe Biomedical Radiochemistry Laboratory, Department of Applied Mathematics, Research School of Physics, Australian National UniversityThe Biomedical Radiochemistry Laboratory, Department of Applied Mathematics, Research School of Physics, Australian National UniversityThe Biomedical Radiochemistry Laboratory, Department of Applied Mathematics, Research School of Physics, Australian National UniversityThe Biomedical Radiochemistry Laboratory, Department of Applied Mathematics, Research School of Physics, Australian National UniversityThe Biomedical Radiochemistry Laboratory, Department of Applied Mathematics, Research School of Physics, Australian National UniversitySirtex Medical LtdSirtex Medical LtdSirtex Medical LtdSirtex Medical LtdAbstract Background Understanding the regional vascular delivery of particles to tumour sites is a prerequisite for developing new diagnostic and therapeutic composites for treatment of oncology patients. We describe a novel imageable 67Ga-radiolabelled polymer composite that is biocompatible in an animal tumour model and can be used for preclinical imaging investigations of the transit of different sized particles through arterial networks of normal and tumour-bearing organs. Results Radiolabelling of polymer microspheres with 67Ga was achieved using a simple mix and wash method, with tannic acid as an immobilising agent. Final in vitro binding yields after autoclaving averaged 94.7%. In vivo stability of the composite was demonstrated in New Zealand white rabbits by intravenous administration, and intrahepatic artery instillations were made in normal and VX2 tumour implanted rabbit livers. Stability of radiolabel was sufficient for rabbit lung and liver imaging over at least 3 hours and 1 hour respectively, with lung retention of radiolabel over 91%, and retention in both normal and VX2 implanted livers of over 95%. SPECT-CT imaging of anaesthetised animals and planar imaging of excised livers showed visible accumulation of radiolabel in tumours. Importantly, microsphere administration and complete liver dispersal was more easily achieved with 8 μm diameter MS than with 30 μm MS, and the smaller microspheres provided more distinct and localised tumour imaging. Conclusion This method of producing 67Ga-radiolabelled polymer microspheres is suitable for SPECT-CT imaging of the regional vascular delivery of microspheres to tumour sites in animal models. Sharper distinction of model tumours from normal liver was obtained with smaller MS, and tumour resolution may be further improved by the use of 68Ga instead of 67Ga, to enable PET imaging.https://doi.org/10.1186/s40824-021-00210-0Vascular particle deliveryTumour plexusTumour imagingRadiolabelled polymer microspheresRabbit tumour model
spellingShingle Ross W. Stephens
Gregory D. Tredwell
Jessica L. Bell
Karen J. Knox
Lee A. Philip
Tim J. Senden
Michael J. Tapner
Stephanie A. Bickley
Marcel R. Tanudji
Stephen K. Jones
In vivo tumour imaging employing regional delivery of novel gallium radiolabelled polymer composites
Biomaterials Research
Vascular particle delivery
Tumour plexus
Tumour imaging
Radiolabelled polymer microspheres
Rabbit tumour model
title In vivo tumour imaging employing regional delivery of novel gallium radiolabelled polymer composites
title_full In vivo tumour imaging employing regional delivery of novel gallium radiolabelled polymer composites
title_fullStr In vivo tumour imaging employing regional delivery of novel gallium radiolabelled polymer composites
title_full_unstemmed In vivo tumour imaging employing regional delivery of novel gallium radiolabelled polymer composites
title_short In vivo tumour imaging employing regional delivery of novel gallium radiolabelled polymer composites
title_sort in vivo tumour imaging employing regional delivery of novel gallium radiolabelled polymer composites
topic Vascular particle delivery
Tumour plexus
Tumour imaging
Radiolabelled polymer microspheres
Rabbit tumour model
url https://doi.org/10.1186/s40824-021-00210-0
work_keys_str_mv AT rosswstephens invivotumourimagingemployingregionaldeliveryofnovelgalliumradiolabelledpolymercomposites
AT gregorydtredwell invivotumourimagingemployingregionaldeliveryofnovelgalliumradiolabelledpolymercomposites
AT jessicalbell invivotumourimagingemployingregionaldeliveryofnovelgalliumradiolabelledpolymercomposites
AT karenjknox invivotumourimagingemployingregionaldeliveryofnovelgalliumradiolabelledpolymercomposites
AT leeaphilip invivotumourimagingemployingregionaldeliveryofnovelgalliumradiolabelledpolymercomposites
AT timjsenden invivotumourimagingemployingregionaldeliveryofnovelgalliumradiolabelledpolymercomposites
AT michaeljtapner invivotumourimagingemployingregionaldeliveryofnovelgalliumradiolabelledpolymercomposites
AT stephanieabickley invivotumourimagingemployingregionaldeliveryofnovelgalliumradiolabelledpolymercomposites
AT marcelrtanudji invivotumourimagingemployingregionaldeliveryofnovelgalliumradiolabelledpolymercomposites
AT stephenkjones invivotumourimagingemployingregionaldeliveryofnovelgalliumradiolabelledpolymercomposites